The dust generated during the sandblasting process of the sandblasted and acid-etched (SLA) method, commonly used to treat the surface of Ti dental implants, poses significant challenges in maintaining a clean manufacturing environment and ensuring safe working conditions. Nevertheless, surface modification remains crucial for improved performance of Ti dental implants. To address this problem and propose a clean and simple surface modification process to potentially replace SLA modification, this study aimed to characterize the surfaces of commercially pure Ti (cp-Ti) samples treated by acid etching and compare them with SLA-treated samples in terms of surface roughness (Rq), wettability (assessed through contact angle measurements), mineralized matrix deposition (evaluated through simulated body fluid [SBF] soaking), cell viability, cell differentiation (assessed based on alkaline phosphatase activity), and mineralization (assessed using MTT assay). Acid-etched surfaces exhibited nano- and micro-roughness and higher hydrophilicity than SLA surfaces, which is conducive to forming a highly bioactive TiO2 surface. Moreover, acid-etched samples exhibited earlier hydroxyapatite deposition after SBF soaking than SLA samples. Furthermore, the acid-etched surfaces were nontoxic and displayed significantly higher cell viability and differentiation after seven days than SLA surfaces. These findings suggest that acid etching is a viable alternative to the SLA method, likely offering superior surface bioactivity and biocompatibility.
Chagas disease (CD) is a worldwide public health problem. Benznidazole (BZ) is the drug used to treat it. However, in its commercial formulation, it has significant side effects and is less effective in the chronic phase of the infection. The development of particulate systems containing BZ is therefore being promoted. The objective of this investigation was to develop polymeric nanoparticles loaded with BZ and examine their trypanocidal impact in vitro. Two formulas (BNP1 and BNP2) were produced through double emulsification and freeze drying. Subsequent to physicochemical and morphological assessment, both formulations exhibited adequate yield, average particle diameter, and zeta potential for oral administration. Cell viability was assessed in H9C2 and RAW 264.7 cells in vitro, revealing no cytotoxicity in cardiomyocytes or detrimental effects in macrophages at specific concentrations. BNP1 and BNP2 enhanced the effect of BZ within 48 h using a treatment of 3.90 μg/mL. The formulations notably improved NO reduction, particularly BNP2. The findings imply that the compositions are suitable for preclinical research, underscoring their potential as substitutes for treating CD. This study aids the quest for new BZ formulations, which are essential in light of the disregard for the treatment of CD and the unfavorable effects associated with its commercial product.
Background/Objectives: Gamma irradiation is a promising terminal sterilization method for nanoparticle-based biomedical systems. However, its potential effects on the physicochemical properties and biological performance of multifunctional nanomaterials must be carefully evaluated. This study aimed to assess the structural integrity, sterility, and cytocompatibility of magnetic nanoparticles (MNPs) and bioactive-glass-coated magnetic nanoparticles (MNPBGs), both based on magnetite (Fe3O4), after gamma irradiation. Methods: MNPs and MNPBGs were synthesized and subjected to gamma irradiation at 25 kGy, with additional doses explored in preliminary evaluations. Physicochemical characterizations were performed using XRD, TEM, SAED, and Raman spectroscopy. FTIR analyses were conducted on bioactive glass (BG) controls without magnetite. Sterility was evaluated via microbiological assays. Cytocompatibility and nitric oxide (NO) production were assessed using RAW 264.7 macrophages and Saos-2 osteosarcoma cells. Prussian blue staining was used to evaluate cellular uptake. Results: Gamma irradiation preserved the crystal structure, morphology, and size distribution of the nanoparticles. FTIR revealed only minor changes in the silicate network of BG, such as reduced intensity and slight shifting of Si-O-Si and Si-O-NBO bands, indicating limited radiation-induced structural rearrangement without affecting the material’s stability or cytocompatibility. Microbiological assays confirmed complete inhibition of microbial growth. All irradiated samples exhibited high cytocompatibility, with MNPBGs demonstrating enhanced biological responses. Notably, MNPBGs induced a more pronounced NO production in macrophages. Cellular uptake of nanoparticles by Saos-2 cells remained unaffected after irradiation. Conclusions: Gamma irradiation at 25 kGy is an effective sterilization strategy that maintains the structural and functional integrity of MNPs and MNPBGs. These findings support their safe use in sterile biomedical applications, particularly for bone-related therapies involving immunomodulation and drug delivery, with potential relevance for cancer treatment strategies such as osteosarcoma.
21 February 2024 in Materials Chemistry and Physics
Fused Deposition Modelling (FDM) is an additive manufacturing technique that has become widely used in many fields of engineering and has recently proven to be suitable for producing complex, net-shaped bonded Nd-Fe-B magnets. At the same time, recycling end-of-life magnets has been an emerging concern due to their increasing presence in current technologies and the intrinsic scarcity of rare-earth elements (REE) such as neodymium and praseodymium. Here, we investigated the feasibility of using recycled nanocrystalline Nd-Fe-B powders, obtained from HDDR process, in the preparation of FDM feedstock and subsequent printing of magnetic parts. Recycled magnetic powder was mixed with polylactic acid (PLA) and extruded into filaments containing increasing volume fractions of magnetic powder. It was possible to obtain filaments containing from 6.7% to 23.6% in volume (30.4 to 65.2 wt.%) of the magnetic powder, from which parts could be printed, reaching maximum coercivity (Hcj) of 707.7 ± 3.5 kA/m, maximum remanence (Br) of 84.5 ± 0.4 mT, maximum energy product (BHmax) of 1.3 kJ/m3 and average part porosity of 42 ± 8%. Coercivity loss of about 8.6% was observed in the printed parts compared to the recycled powder (750±75 kA/m). Aging experiments showed that such loss may be a combined effect of thermal and oxidation effects of the magnetic particles during AM processing. The present work has innovatively demonstrated the achievement of ready-to-use, high-coercivity FDM filaments, and 3D-printed parts using recycled Nd-Fe-B HDDR powders.
Ti and its alloys are standard materials providing a bioinert surface for osseointegrated implant devices. However, developing bioactive surfaces for such applications is a great challenge in biomaterial surface engineering. This study investigates the surface modification of titanium by depositing thin films of niobium and titanium-niobium alloys using magnetron sputtering. The overall objective is to evaluate the effect of Nb introduction on the physicochemical, structural, and biological properties of the surface. Analysis via scanning electron microscopy and atomic force microscopy demonstrated that thermal treatment at moderate temperatures (500–750°C) promotes grain growth and alters surface roughness. X-ray diffraction indicated the coexistence of phases and temperature-dependent structural alterations. Contact angle measurements confirmed the surface hydrophilicity, with values suitable for biomedical applications. In vitro assays with MC3T3-E1 pre-osteoblastic cells demonstrated biocompatibility with cell viability >70%. Furthermore, alkaline phosphatase activity and extracellular matrix mineralization were satisfactory over 14 and 21 days. Although the surfaces did not show direct antimicrobial activity against Staphylococcus aureus, this neutrality is considered advantageous for preserving the peri-implant biological ecosystem. Therefore, the developed Nb and Ti-Nb coatings prove to be a promising and innovative strategy for enhancing the bioactivity of metallic implants.